Tumor Angiogenesis
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Machine scores (provisional)
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
- Teacher spread
- 0.288 · how far apart the two teachers sit on this one work
- Validation status
score_only:v0-immature-baseline· verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it
Abstract
The dependency of the growth of tumors on blood vessels, once considered a doubtful proposition, has become a major avenue of research and drug development. This review discusses the results of recent investigations into tumor angiogenesis and surveys the mechanisms of action of antibodies and drugs that inhibit angiogenesis.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
The record
- Venue
- New England Journal of Medicine
- Topic
- Angiogenesis and VEGF in Cancer
- Field
- Biochemistry, Genetics and Molecular Biology
- Canadian institutions
- Sunnybrook Health Science Centre
- Funders
- Canadian Institutes of Health ResearchGenentechAstraZenecaNational Cancer InstituteNational Institutes of HealthPfizerBristol-Myers Squibb
- Keywords
- AngiogenesisMedicineNeovascularizationCancer researchImmunology
- Has abstract in OpenAlex
- yes